Kardigan, Inc. (KARD) Stock Price & Analysis
Kardigan, Inc. (KARD) closed at USD 13.88 on Thursday, October 15, 2026, up 2.66% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 13.52; the Oct 15, 2026 session ranged USD 13.13–14.13 on volume of 660,929 shares. Market capitalization is $1.30B, with a 52-week range of USD 12.23–27 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/KARD.md
Key facts (KARD)
- Analysts: Buy (mean 1.80 on a 1–5 scale) (5 analysts), mean target USD 38.8 (range 25–46).
- Total return with dividends: 1Y -36.9% vs S&P 500 +18.1%; 5Y -36.9% vs S&P 500 +85.1%.
- Next earnings: 2026-11-09, EPS estimate USD -0.76, revenue estimate $0K.
Analysts (KARD)
Consensus Buy (mean 1.80 on a 1–5 scale), 5 analysts; mean target USD 38.8 (low 25, high 46).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | UBS | Initiated | Buy | $25 |
| 2026-08-25 | JP Morgan | Target lowered | Overweight | $51 → $46 |
| 2026-07-13 | TD Cowen | Initiated | Buy | $46 |
| 2026-07-13 | Leerink Partners | Initiated | Outperform | $37 |
| 2026-07-13 | JP Morgan | Initiated | Overweight | $51 |
| 2026-07-13 | Jefferies | Initiated | Buy | $40 |
Total return (dividends reinvested) (KARD)
| 1Y (from 2026-06-18) | 5Y (from 2026-06-15) | |
|---|---|---|
| Total return | -36.9% | -36.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 72.3% | 45.2% |
| Max drawdown | -49.9% (Jun 2026→Oct 2026) | -43.7% (Jul 2026→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 13.88 |
|---|---|
| Change | ▲ 2.66% (up) |
| Previous Close | USD 13.52 |
| Open | USD 13.8 |
| Day Range | USD 13.13 – 14.13 |
| 52-Week Range | USD 12.23 – 27 |
| Volume | 660,929 shares |
| Market Cap | $1.30B |
| Exchange | NGM |
Technical Analysis (KARD)
Nexqual's technical model rates KARD "STRONG SELL" based on 0 bullish and 5 bearish signals across 83 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 39.11 (neutral) |
| vs SMA50 | Below (USD 18.04) |
| MACD | -1.26 (negative) |
Analyst Ratings (KARD)
Wall Street analysts rate KARD "Buy" based on 5 analysts, with a mean price target of USD 38.8 (range USD 25–46), per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 38.8 |
| High Target | USD 46 |
| Low Target | USD 25 |
| Buy / Hold / Sell | 5 / 0 / 0 |
Earnings (KARD)
| Next Earnings Date | 2026-11-09 |
|---|---|
| EPS Estimate | USD -0.76 |
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -2.89 vs est -0.64 ▼ miss |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (KARD)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Debt / Equity | 0.02 |
| Current Ratio | 8.72 |
| Total Cash | $597.60M |
| Total Debt | $13.35M |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (KARD)
Nexqual rates Kardigan, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $598M cash vs $13M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$206M (TTM) |
| Efficiency | Mixed — No data |
Ownership (KARD)
| Insider Ownership | +15.58% |
|---|---|
| Institutional Ownership | +78.31% |
| Shares Outstanding | 93.50M |
| Float | 51.76M |
| Short % of Float | +5.57% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (KARD)
Kardigan, Inc. is led by Tassos Anastasios E. Gianakakos M.Sc. (age 52), Co-Founder, President, CEO & Chairman, per Nexqual as of October 16, 2026 at 05:21 UTC.
| Co-Founder, President, CEO & Chairman | Tassos Anastasios E. Gianakakos M.Sc. (age 52) |
|---|---|
| Chief Financial Officer | Brianne Puglisi (age 38) |
| Vice President of Investor Relations | Clayton Robertson |
Major Backers & Investors (KARD)
Notable institutional backers of Kardigan, Inc. include HRTG GPE, LLC, FMR, LLC, Perceptive Advisors Llc, according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| HRTG GPE, LLC | 18.09% |
| FMR, LLC | 9.53% |
| Perceptive Advisors Llc | 8.77% |
| T. Rowe Price | 6.45% |
| Capital Group | 3.85% |
| SmallCap World Fund Inc | 3.75% |
| JPMorgan | 2.8% |
| Fidelity | 1.98% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 87.97 | ▲ 1.57% |
| BLTE | Belite Bio, Inc | USD 152.62 | ▲ 0.49% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.72 | ▲ 1.52% |
| PRAX | Praxis Precision Medicines, Inc | USD 248.24 | ▲ 2.01% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 44.12 | ▲ 4.11% |
| SYRE | Spyre Therapeutics, Inc. | USD 80.1 | ▼ 0.44% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt